|
Q3 2022
|
4 |
37,881 |
ASND, I9SA.HA, NTRA, CBAY
|
13F-HR
|
11/14/2022 |
000110465922117991 |
|
Q2 2022
|
4 |
27,568 |
ASND, NTRA, CBAY, I9SA.HA
|
13F-HR
|
8/12/2022 |
000110465922089758 |
|
Q1 2022
|
4 |
32,815 |
ASND, NTRA, I9SA.HA, CBAY
|
13F-HR
|
5/13/2022 |
000110465922059934 |
|
Q4 2021
|
4 |
39,499 |
ASND, NTRA, I9SA.HA, CBAY
|
13F-HR
|
2/11/2022 |
000110465922020349 |
|
Q3 2021
|
6 |
72,113 |
ACRS, XLRN, I9SA.HA, CBAY
|
13F-HR
|
11/12/2021 |
000110465921137698 |
|
Q2 2021
|
8 |
94,339 |
ACRS, NTRA, XLRN, EPZM
|
13F-HR
|
8/16/2021 |
000110465921105287 |
|
Q1 2021
|
8 |
113,881 |
ACRS, XLRN, NTRA, FGEN
|
13F-HR
|
5/17/2021 |
000110465921067102 |
|
Q4 2020
|
8 |
86,035 |
Oric Pharmaceuticals, Inc., XLRN, NTRA, FGEN
|
13F-HR
|
2/16/2021 |
000110465921023079 |
|
Q3 2020
|
10 |
134,301 |
MYOK, NTRA, Oric Pharmaceuticals, Inc., XLRN
|
13F-HR
|
11/13/2020 |
000110465920124781 |
|
Q2 2020
|
8 |
112,465 |
MYOK, BPMC, ORIC, EPZM
|
13F-HR
|
8/13/2020 |
000110465920094442 |
|
Q1 2020
|
9 |
62,801 |
MYOK, EPZM, BPMC, NTRA
|
13F-HR
|
5/14/2020 |
000110465920061248 |
|
Q4 2019
|
10 |
178,435 |
Aerie Pharmaceuticals, Inc., IMMU, MYOK, EPZM
|
13F-HR
|
2/14/2020 |
000110465920021577 |
|
Q3 2019
|
14 |
261,893 |
Aerie Pharmaceuticals, Inc., ALDR, BPMC, IMMU
|
13F-HR
|
11/13/2019 |
000110465919062960 |
|
Q2 2019
|
18 |
304,928 |
Aerie Pharmaceuticals, Inc., BPMC, ALDR, IMMU
|
13F-HR
|
8/13/2019 |
000114420419039330 |
|
Q1 2019
|
19 |
384,166 |
Aerie Pharmaceuticals, Inc., IMMU, ALDR, BPMC
|
13F-HR
|
5/14/2019 |
000114420419025826 |
|
Q4 2018
|
22 |
304,474 |
Aerie Pharmaceuticals, Inc., IMMU, ALDR, BPMC
|
13F-HR
|
2/13/2019 |
000114420419007306 |
|
Q3 2018
|
24 |
453,219 |
Aerie Pharmaceuticals, Inc., IMMU, ALDR, RCUS
|
13F-HR
|
11/13/2018 |
000114420418059270 |
|
Q2 2018
|
24 |
464,374 |
Aerie Pharmaceuticals, Inc., IMMU, ALDR, RCUS
|
13F-HR
|
8/14/2018 |
000114420418044629 |
|
Q1 2018
|
24 |
458,816 |
Aerie Pharmaceuticals, Inc., RCUS, IMMU, ALDR
|
13F-HR
|
5/15/2018 |
000114420418028463 |
|
Q4 2017
|
17 |
356,346 |
Aerie Pharmaceuticals, Inc., IMMU, ALDR, BPMC
|
13F-HR
|
2/13/2018 |
000114420418007692 |
|
Q3 2017
|
20 |
363,051 |
Aerie Pharmaceuticals, Inc., ALDR, IMMU, BPMC
|
13F-HR
|
11/13/2017 |
000114420417058213 |
|
Q2 2017
|
26 |
306,137 |
Aerie Pharmaceuticals, Inc., AKAOQ, ALDR, BPMC
|
13F-HR
|
8/14/2017 |
000114420417042942 |
|
Q1 2017
|
25 |
260,549 |
Aerie Pharmaceuticals, Inc., ALDR, AKAOQ, AIMT
|
13F-HR
|
5/12/2017 |
000114420417026663 |
|
Q4 2016
|
20 |
230,122 |
Aerie Pharmaceuticals, Inc., AKAOQ, ALDR, AIMT
|
13F-HR
|
2/10/2017 |
000114420417007452 |
|
Q3 2016
|
17 |
213,950 |
Aerie Pharmaceuticals, Inc., ALDR, WVE, AIMT
|
13F-HR
|
11/14/2016 |
000114420416133777 |
|
Q2 2016
|
18 |
145,736 |
ALDR, Aerie Pharmaceuticals, Inc., WVE, NTLA
|
13F-HR
|
8/12/2016 |
000114420416118727 |
|
Q1 2016
|
23 |
129,247 |
ALDR, WVE, Aerie Pharmaceuticals, Inc., Global Blood Therapeutics, Inc.
|
13F-HR
|
5/6/2016 |
000114420416099540 |
|
Q4 2015
|
19 |
112,755 |
WVE, Global Blood Therapeutics, Inc., ALDR, EPZM
|
13F-HR
|
2/12/2016 |
000114420416081047 |